<DOC>
	<DOCNO>NCT00198445</DOCNO>
	<brief_summary>The primary objective study investigate efficacy bromfenac sodium ophthalmic solution 0.09 % treatment post-operative ocular inflammation subject undergo cataract extraction intraocular lens implantation . The secondary objective investigate safety tolerability .</brief_summary>
	<brief_title>Safety Efficacy Study Topical Bromfenac Versus Placebo Treat Ocular Inflammation After Cataract Surgery</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Postoperative Complications</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Cataract surgery Summed ocular inflammation score ( anterior chamber cell score plus flare score ) &gt; /= 3 , 24 hour cataract extraction Agreed avoid disallow medication ( med ) throughout duration study Use need nonsteroidal antiinflammatory agent ( NSAIDs ) , steroid , anticoagulant , specific med prohibit protocol Uncontrolled chronic ocular systemic disease , active corneal pathology scar note either eye ( except keratopathy , allow nonstudy eye ) Extraocular/intraocular inflammation either eye Clinically significant ( WHO CTC Grade 1 great ) liver function test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Cataract Extraction</keyword>
	<keyword>Anti-Inflammatory Agents , Non-Steroidal</keyword>
</DOC>